Optometry and Vision Science · 2005 · 32 citations · 4 references
MedicineDermatologyMaxillofacial PathologyNeurotoxicologyOrofacial PainBotulinum Toxin TherapyBotulinum Toxin TreatmentBotulinum NeurotoxinBotulinum Toxin DosageBotulinum ToxinsMedication Adverse EffectsNeurotoxin InjectionsOromandibular Dystonia
PURPOSE: : Botulinum neurotoxins are considered relatively safe therapy for treatment of inappropriate muscle spasms. As seen in this report, undesirable consequences may result. METHODS: : The author conducted a clinical interview and examination of the patient. RESULTS: : Unilateral left-sided madarosis and facial alopecia were observed in a patient undergoing botulinum A toxin injections for the treatment of left oromandibular dystonia. The patient had started treatment 18 months previously. He received injections every 3 months in the left masseter and left temporalis muscles. He first noted loss of his left sideburn 8 months into treatment. After 10 months of treatment, he noted that he no longer needed to shave on the left side of his face. Eighteen months after receiving his first botulinum toxin injection, madarosis of the temporal aspect of the left lower lid was observed. CONCLUSIONS: : This is the first case report documenting an idiosyncratic unilateral madarosis and facial alopecia as adverse side effects presumed secondary to botulinum A toxin injections.
4
Effects of botulinum toxin type A on intracortical inhibition in patients with dystonia
F. Gilio, A. Curr�, C. Lorenzano et al. · Annals of Neurology · 2000 · 226 citations · Full text
Medicine, Neurology, Neuroscience +17
Botulinum toxin A in patients with oromandibular dystonia
Eng‐King Tan, Joseph Jankovic · Neurology · 1999 · 199 citations
C. Carolyn Thiedke · PubMed · 2003 · 36 citations
Medicine, Dermatology, Endocrinology +15